3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Recurrence
2
Osteosarcoma
2
Hematologic Neoplasms
2
Wilms Tumor
1
Sarcoma, Ewing
1
Sarcoma, Clear Cell
1
Sarcoma
1
Rhabdomyosarcoma
1
Rhabdoid Tumor
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Neurofibrosarcoma
1
Neuroblastoma
1
Neoplasms, Germ Cell and Embryonal
1
Myelodysplastic Syndromes
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Leukemia, Myelomonocytic, Juvenile
1
Leukemia, Myeloid, Acute
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Lymphoid
1
Leukemia, Large Granular Lymphocytic
1
Leukemia, B-Cell
1
Leukemia
1
Hodgkin Disease
1
Hepatoblastoma
1
Desmoplastic Small Round Cell Tumor
1
Carcinoma
1
Burkitt Lymphoma
1
Blastic Plasmacytoid Dendritic Cell Neoplasm
1
Interventions
Carboplatin
29
pembrolizumab
25
Pemetrexed
25
Specimen Handling
22
Cisplatin
20
Magnetic Resonance Spectroscopy
18
Paclitaxel
15
Gemcitabine
13
Docetaxel
12
durvalumab
9
Nivolumab
8
osimertinib
7
Taxes
7
Immunoglobulin G
7
Disulfides
7
130-nm albumin-bound paclitaxel
7
atezolizumab
6
Etoposide
6
Platinum
5
Cetuximab
5
1,2-diaminocyclohexaneplatinum II citrate
5
X-Rays
4
Ramucirumab
4
Radiotherapy
4
Radiation
4
Observation
4
Interviews as Topic
4
Biopsy
4
Albumin-Bound Paclitaxel
4
patritumab deruxtecan
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lung Neoplasms
×
Mesna
×
30 days
×
Clear all
No trials found.